Vistin Pharma ASA (OSE: VISTIN): Invitation to Capital Markets Day on 14th of June at the metformin manufacturing plant in Kragerø
May 11, 2023 05:00 ET
|
Vistin Pharma ASA
Vistin Pharma will host a Capital Markets Day (CMD) for all interested parties on the 14th of June at its production plant in Stuttlidalen 4 at Fikkjebakke in Kragerø. The invitation is attached. ...
Notice of Annual General Meeting in Vistin Pharma ASA
April 28, 2023 06:30 ET
|
Vistin Pharma ASA
Oslo, Norway, 28 April 2023 Vistin Pharma ASA (OSE: VISTIN), please find attached the call for the Annual General Meeting in Vistin Pharma, to be held on 22 May at 13:00 CEST. A physical Annual...
Vistin Pharma ASA: Annual Report for 2022
April 27, 2023 11:35 ET
|
Vistin Pharma ASA
Oslo, Norway, 27 April 2023 Please find attached the Annual Report for 2022 for Vistin Pharma ASA. There are no material changes in the financial statements compared to the preliminary full year...
Vistin Pharma ASA: First quarter 2023 financial results
April 27, 2023 01:50 ET
|
Vistin Pharma ASA
Oslo, Norway, 27th of April 2023 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces the financial results for the first quarter of 2023. Revenue in the first quarter ended at MNOK 101...
Vistin Pharma ASA: Invitation to Q1 2023 conference call
April 20, 2023 05:00 ET
|
Vistin Pharma ASA
Oslo, Norway, 20 April 2023 Vistin Pharma ASA will release its first quarter 2023 results on Thursday 27th of April 2023. Vistin Pharma will host a conference call for all shareholders and...
Vistin Pharma ASA: Fourth quarter and preliminary 2022 financial results
February 17, 2023 02:00 ET
|
Vistin Pharma ASA
Oslo, Norway, 17th of February 2023 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces the financial results for the fourth quarter 2022 Det company enjoyed a very strong finishing...
Vistin Pharma ASA: Invitation to Q4 2022 conference call
February 10, 2023 04:00 ET
|
Vistin Pharma ASA
Oslo, Norway, 10 February 2023 Vistin Pharma ASA will release its fourth quarter and preliminary 2022 results on Friday 17th of February 2023. Vistin Pharma will host a conference call for all...
Vistin Pharma enters into a long-term renewable energy supply agreement with Statkraft
December 09, 2022 06:10 ET
|
Vistin Pharma ASA
Oslo, Norway, 9 December 2022 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) announces that it has entered into a long-term industrial energy agreement with Statkraft, the leading Norwegian energy...
Vistin Pharma ASA: Third quarter and YTD 2022 financial results
October 26, 2022 01:45 ET
|
Vistin Pharma ASA
Oslo, Norway, 26th of October 2022 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces the financial results for the third quarter 2022 Strong revenue growth in the quarter compared...
Vistin Pharma ASA: Invitation to Q3 2022 conference call
October 18, 2022 08:00 ET
|
Vistin Pharma ASA
Oslo, Norway, 18 October 2022 Vistin Pharma ASA will release its third quarter and YTD 2022 results on Wednesday 26th of October 2022. Vistin Pharma will host a conference call for all shareholders...